Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Financial Flexibility Index
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥530.90 Million (operating CF CN¥446.51 Million minus capex CN¥84.38 Million) represents 0% of total liabilities (CN¥3.52 Billion). Also explore Shijiazhuang Yiling Pharmaceutical Co Lt annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shijiazhuang Yiling Pharmaceutical Co Ltd across 18 annual periods. Check Shijiazhuang Yiling Pharmaceutical Co Lt strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shijiazhuang Yiling Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Shijiazhuang Yiling Pharmaceutical Co Lt stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | CN¥2.02 Billion | CN¥1.78 Billion | CN¥2.69 Billion | ▲ +159.6% |
| 2024 | 0.29x | CN¥901.40 Million | CN¥611.01 Million | CN¥3.12 Billion | ▲ +243.7% |
| 2023 | 0.08x | CN¥466.29 Million | CN¥155.46 Million | CN¥5.54 Billion | ▼ -87.7% |
| 2022 | 0.68x | CN¥3.70 Billion | CN¥3.49 Billion | CN¥5.41 Billion | ▲ +118.1% |
| 2021 | 0.31x | CN¥1.20 Billion | CN¥528.69 Million | CN¥3.83 Billion | ▼ -70.3% |
| 2020 | 1.06x | CN¥2.73 Billion | CN¥1.59 Billion | CN¥2.58 Billion | ▲ +125.5% |
| 2019 | 0.47x | CN¥523.35 Million | CN¥68.93 Million | CN¥1.12 Billion | ▲ +79.3% |
| 2018 | 0.26x | CN¥259.59 Million | CN¥72.37 Million | CN¥993.56 Million | ▼ -31.3% |
| 2017 | 0.38x | CN¥295.00 Million | CN¥114.65 Million | CN¥775.58 Million | ▼ -65.3% |
| 2016 | 1.10x | CN¥1.01 Billion | CN¥641.45 Million | CN¥925.04 Million | ▲ +58.0% |
| 2015 | 0.69x | CN¥610.31 Million | CN¥131.88 Million | CN¥879.56 Million | ▼ -16.3% |
| 2014 | 0.83x | CN¥556.10 Million | CN¥105.90 Million | CN¥671.19 Million | ▼ -28.8% |
| 2013 | 1.16x | CN¥465.15 Million | CN¥55.32 Million | CN¥399.69 Million | ▲ +1.7% |
| 2012 | 1.14x | CN¥367.02 Million | CN¥70.13 Million | CN¥320.75 Million | ▲ +359.9% |
| 2011 | -0.44x | CN¥-230.59 Million | CN¥-408.49 Million | CN¥523.78 Million | ▼ -151.2% |
| 2010 | 0.86x | CN¥584.74 Million | CN¥299.72 Million | CN¥680.08 Million | ▲ +16.9% |
| 2009 | 0.74x | CN¥528.78 Million | CN¥318.21 Million | CN¥718.89 Million | ▼ -24.4% |
| 2008 | 0.97x | CN¥338.45 Million | CN¥210.18 Million | CN¥347.88 Million | — |